Yahoo Web Search

Search results

1. www.regeneron.comRegeneron Pharmaceuticals: Delivering Life-transforming Medicines

   www.regeneron.com

   • Cached

   Regeneron is a biotech company that develops new medicines for serious diseases, such as cancer, asthma and COVID-19. Learn about their scientific breakthroughs, clinical trials, responsibility goals and career opportunities.

   • Scientists

     Rapid response to infectious diseases. How can we go even...

   • Patients

     Compassionate use: Access to investigational medicines....

   • Medical Professionals

     Regeneron’s Compassionate Use Policy gives certain patients...

   • Investors and Media

     We are a leading science and technology company that...

   • Careers

     Working at Regeneron We are a team of original thinkers who...

   • Leadership

     Leonard (Len) Brooks joined Regeneron in 2013 and serves as...

   • About

     At Regeneron, we move science to medicine because our world...

   • Grants & Funding

     Regeneron is committed to conducting business in compliance...

2. en.wikipedia.org › wiki › Regeneron_PharmaceuticalsRegeneron Pharmaceuticals - Wikipedia

   en.wikipedia.org › wiki › Regeneron_Pharmaceuticals

   • Cached

   Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.

3. Images

   • 
   • 
   • 
   • 

   View all

4. www.regeneron.com › globalRegeneron Pharmaceuticals: Delivering Life-transforming Medicines

   www.regeneron.com › global

   • Cached

   Regeneron is a leading biotechnology company using the power of science to bring new medicines to patients in need. Explore Regeneron's global presence.

5. www.regeneron.com › aboutAbout Regeneron Pharmaceuticals: Innovative Biotechnology

   www.regeneron.com › about

   • Cached

   Regeneron is a biotech company that invents and develops medicines for serious diseases, such as eye, allergic, inflammatory, cancer, and rare diseases. Founded and led by physician-scientists, Regeneron uses proprietary technologies and genetics sequencing to create life-transforming treatments.

6. Videos

   • 

     8:51

     youtube.com

     The Rise of Regeneron Pharmaceuticals: Exploring the Company's Success Factors and Stock Valuation

     15 Jun 2023

     422 views

   • 

     10:35

     youtube.com

     Regeneron Pharmaceuticals: Finding Stock Market Winners

     7 Feb 2024

     59 views

   • 

     17:19

     youtube.com

     From “The Way Forward" Conference: Dr. Leonard S. Schleifer, Co-Founder, Regeneron Pharmaceuticals

     7 Jul 2020

     3.4K views

   View all

7. Top stories

   • Business Insider

     Regeneron Pharma Expects Q4 Results To Include $24 Mln In Acquired In-process R&D Charge

     Regeneron Pharmaceuticals, Inc. (REGN) said Monday it currently expects that its financial results for the second quarter 2024 will

     7 hours ago

   • Morningstar

     Regeneron Expects Earnings Hit After $24 Million R&D Charge

     Regeneron Pharmaceuticals expects to incur an acquired in-process research and development charge of about $24 million in the second quarter, which should negatively impact earnings per share. The biotechnology company said the charge will likely hit net income per diluted share for the quarter by roughly 18 cents.

     8 hours ago

   • 

     Stockhouse

     The Schall Law Firm Initiates Probe Into Claims Against Regeneron Pharmaceuticals Inc And Encourages Affected Investors To Make Contact

     2 hours ago

   • Benzinga on MSN.com

     What's Going On With Regeneron Pharmaceuticals Stock On Friday?

     1 week ago

   • FiercePharma

     Sanofi and Regeneron's Dupixent scores in Europe as the first biologic to treat COPD

     5 days ago

   View all

8. newsroom.regeneron.com › news-releases › news-release-detailsINVESTORS & MEDIA - Regeneron Pharmaceuticals Inc.

   newsroom.regeneron.com › news-releases › news-release-details

   • Cached

   Jul 30, 2021 · Regeneron announces FDA expanded authorization of REGEN-COV™, a COVID-19 antibody cocktail, for post-exposure prophylaxis in certain high-risk people. REGEN-COV is the only antibody therapy available for both treatment and prevention of COVID-19 in the U.S.

9. investor.regeneron.com › news-releases › news-release-detailsDupixent® (dupilumab) Approved in the European Union as the...

   investor.regeneron.com › news-releases › news-release-details

   • Cached

   5 days ago · When Regeneron 's co-Founder, President and Chief Scientific Officer George D. Yancopoulos was a graduate student with his mentor Frederick W. Alt in 1985, they were the first to envision making such a genetically humanized mouse, and Regeneron has spent decades inventing and developing VelocImmune and related VelociSuite ® technologies.

10. newsroom.regeneron.com › news-releases › news-release-detailsINVESTORS & MEDIA - Regeneron Pharmaceuticals Inc.

    newsroom.regeneron.com › news-releases › news-release-details

    • Cached

    Mar 23, 2021 · FDA recently updated U.S. EUA fact sheets for all authorized monoclonal antibody treatments, indicating that REGEN-COV is the only one to retain potency against key emerging variants. Regeneron will share new data with regulatory authorities immediately and request that a lower 1,200 mg dose be added to EUA.